Stryker Corp
SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)
Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –
Stryker Legacy Neurotechnology Franchise by Year
Legacy Neurotechnology Franchise (through FY2022Q4) — Worldwide Sales ($M) ($M)
Stryker Legacy Neurotechnology Franchise: $1,945M in FY2020, down 1.4% from a year earlier. No newer figure appears in the documents we track.
Latest, FY2020
1,945
Period ended Dec 31, 2020
Change on a year earlier
-1.4%
1,973 in FY2019
History
7 years
Since FY2014
Sources
6
Documents cited below
Where the FY2020 figure comes from
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Legacy Neurotechnology Franchise (through FY2022Q4) — Worldwide Sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2020 | Dec 31, 2020 | 1,945 | -1.4% | 0000310764-21-000005|sykex991earningsq42020.htm ↗ |
| FY2019 | Dec 31, 2019 | 1,973 | +13.6% | 0000310764-20-000004|sykex991earningsq42019.htm ↗ |
| FY2018 | Dec 31, 2018 | 1,737 | +22.1% | 0000310764-19-000006|sykex991earnings1292019.htm ↗ |
| FY2017 | Dec 31, 2017 | 1,423 | +13.4% | 0000310764-18-000014|sykex991earningsrelea13017.htm ↗ |
| FY2016 | Dec 31, 2016 | 1,255 | +15.3% | 0000310764-17-000014|sykex991earningsrelease12417.htm ↗ |
| FY2015 | Dec 31, 2015 | 1,088 | +8.7% | 0000310764-16-000203|sykexhibit99101262016.htm ↗ |
| FY2014 | Dec 31, 2014 | 1,001 | – | 0000310764-16-000203|sykexhibit99101262016.htm ↗ |
Cite this data
StockData. (2026). Stryker Legacy Neurotechnology Franchise ($M), annual FY2014–FY2020 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/leg-neurotech-ww
See every metric in the Stryker KPI table. Data updated Nov 2, 2026.